⌕
Integra Lifesciences Holdings · IART · Nasdaq
Tenet 41 · Weak
Compare
$13.98−2.92%At closeTenet 41 · Weak
$13.98−0.42 (−2.92%)
At close: Nov 16, 2026, 4:00 PM ET· Nasdaq · USD

Integra Lifesciences Holdings (IART) News

What's actually happening: chronological and provenance-stamped. News is context, not a signal.

Sources News publishers NewsHow we compute thisNot investment advice

● GlobeNewsWireNov 10, 2026 · 17:23 ET
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Integra LifeSciences Holding Corporation - IART

NEW YORK, Nov. 10, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Integra LifeSciences Holding Corporation (“Integra” or the “Company”) (NASDAQ: IART).  Such investors are advise…

● Seeking AlphaNov 10, 2026 · 02:11 ET
Integra LifeSciences Holdings Corporation (IART) Presents at 2026 UBS Global Healthcare Conference Transcript

Integra LifeSciences Holdings Corporation (IART) Presents at 2026 UBS Global Healthcare Conference Transcript…

● GlobeNewsWireNov 6, 2026 · 08:00 ETCOMPANY'S OWN WORDS
Integra LifeSciences to Present at the 2026 UBS Global Healthcare Conference

PRINCETON, N.J., Nov. 06, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today announced that Lea Knight, chief financial officer, will pre…

● PRNewsWireNov 5, 2026 · 19:42 ET
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Integra LifeSciences Holding Corporation - IART

NEW YORK, Nov. 5, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Integra LifeSciences Holding Corporation ("Integra" or the "Company") (NASDAQ: IART).  Such investors are advised to …

● GlobeNewsWireOct 30, 2026 · 08:30 ETCOMPANY'S OWN WORDS
Integra LifeSciences to Highlight Hands-On Education and Neurosurgery Innovation at CNS 2026 Annual Meeting

PRINCETON, N.J., Oct. 30, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a global leader in medical technology, today announced its participation in the 2026 Congress of Neurological S…

● PRNewsWireOct 29, 2026 · 10:00 ET
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Integra LifeSciences Holding Corporation - IART

NEW YORK, Oct. 29, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Integra LifeSciences Holding Corporation ("Integra" or the "Company") (NASDAQ: IART). Such investors are advised to …

● Seeking AlphaOct 23, 2026 · 12:21 ET
Integra LifeSciences: Progress Remains Frustratingly Slow, But Valuation Is Getting Interesting

Integra LifeSciences remains pressured by operational challenges, but restructuring and a returning CEO offer renewed turnaround potential. IART's Wound Reconstruction business continues to underperform, though upcoming …

● Business WireOct 23, 2026 · 11:00 ET
Lost Money on Integra LifeSciences Holdings Corporation Stock? Glancy Prongay Wolke & Rotter LLP Investigates Possible Securities Fraud After 21.2% Share Price Drop

LOS ANGELES--(BUSINESS WIRE)--Investors who lost money on Integra LifeSciences Holdings Corporation ("Integra" or the "Company") stock may have claims to recover their losses. Glancy Prongay Wolke & Rotter LLP ("Glancy")…

● Business WireOct 23, 2026 · 09:00 ET
Did You Lose Money on Integra LifeSciences Holdings Corporation Stock? The Law Offices of Howard G.

BENSALEM, Pa.--(BUSINESS WIRE)--Investors who suffered losses on Integra LifeSciences Holdings Corporation ("Integra" or the "Company") stock may have claims to recover those losses. The Law Offices of Howard G. Smith to…

● Business WireOct 22, 2026 · 12:14 ET
Lost Money on Integra LifeSciences Holdings Corporation Shares? The Law Offices of Frank R.

LOS ANGELES--(BUSINESS WIRE)--Integra LifeSciences Holdings Corporation ("Integra" or the "Company") investors who lost money may have claims to recover their losses. The Law Offices of Frank R. Cruz today announced it i…

● Newsfile CorpOct 21, 2026 · 18:00 ET
Integra LifeSciences Holdings Corporation Investigation Continues: Investors May Contact Kirby McInerney LLP, a Securities Fraud Law Firm, If You Lost Money On Your IART Investments

New York, New York--(Newsfile Corp. - October 21, 2026) - The law firm of Kirby McInerney LLP continues its investigation on behalf of Integra LifeSciences Holdings Corporation ("Integra" or the "Company") (NASDAQ: IART)…

● Seeking AlphaOct 21, 2026 · 14:29 ETEARNINGS EXPECTED BY FEB 24
Integra LifeSciences Holdings Corporation (IART) Q3 2026 Earnings Call Transcript

Integra LifeSciences Holdings Corporation (IART) Q3 2026 Earnings Call Transcript…

● Fool - Investing NewsOct 21, 2026 · 13:51 ET
Integra: 3 Key Takeaways for Long-Term Investors

Operating cash flow hit a record even as the company navigates supply disruptions, a sign of underlying business resilience.…

● MarketBeatOct 21, 2026 · 12:05 ETEARNINGS EXPECTED BY FEB 24
What Integra LifeSciences (IART) Said on Its Q3 Earnings Call

Integra LifeSciences NASDAQ: IART reported third-quarter revenue at the low end of its guidance range as a flooding-related disruption at its Cincinnati facility and slower-than-expected Tissue Reconstruction performance…

● Zacks Investment ResearchOct 21, 2026 · 10:31 ETEARNINGS EXPECTED BY FEB 24
Integra (IART) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

Although the revenue and EPS for Integra (IART) give a sense of how its business performed in the quarter ended September 2026, it might be worth considering how some key metrics compare with Wall Street estimates and th…

● Zacks Investment ResearchOct 21, 2026 · 08:26 ETEARNINGS EXPECTED BY FEB 24
Integra LifeSciences (IART) Surpasses Q3 Earnings Estimates

Integra LifeSciences (IART) came out with quarterly earnings of $0.59 per share, beating the Zacks Consensus Estimate of $0.56 per share. This compares to earnings of $0.54 per share a year ago.…

● GlobeNewsWireOct 21, 2026 · 06:00 ETEARNINGS EXPECTED BY FEB 24
Integra LifeSciences Reports Third Quarter 2026 Financial Results

PRINCETON, N.J., Oct. 21, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today reported financial results for the third quarter ending Sept…

● GlobeNewsWireOct 19, 2026 · 16:05 ET
Integra Announces Completion of Refinancing Transactions

PRINCETON, N.J., Oct. 19, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) today announced that it has closed a private offering of $450.0 million aggregate principal amount of 9.500% seni…

● GlobeNewsWireOct 16, 2026 · 08:39 ET
Integra LifeSciences to Highlight ENT and Instruments Portfolios and Sponsor New Clinical Research Presentations at AAO-HNSF 2026 Annual Meeting

PRINCETON, N.J., Oct. 16, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a global leader in medical technology, today announced its participation in the 2026 American Academy of Otolar…

● Business WireOct 13, 2026 · 18:51 ET
INTEGRA LIFESCIENCES HOLDINGS CORPORATION IART INVESTORS: Contact Kirby McInerney LLP About the Firm's Securities Investigation Following 21.2% Share Drop

NEW YORK--(BUSINESS WIRE)---- $IART #ClassActionLawsuit--The law firm of Kirby McInerney LLP reminds investors of its investigation on behalf of Integra LifeSciences Holdings Corporation (“Integra” or the “Company”) (NAS…

● Defense WorldOct 12, 2026 · 02:15 ET
Integra LifeSciences (NASDAQ:IART) & Precision Optics (NASDAQ:POCI) Critical Review

Precision Optics (NASDAQ: POCI - Get Free Report) and Integra LifeSciences (NASDAQ: IART - Get Free Report) are both small-cap healthcare companies, but which is the better investment? We will compare the two businesses …

● Defense WorldOct 12, 2026 · 02:02 ET
Integra LifeSciences (NASDAQ: IART) prices $450 million notes to refinance debt

What happened Integra LifeSciences Holdings Corporation (NASDAQ: IART) in Princeton, N.J., priced $450 million of 9.500% senior secured notes due 2033 on October 9, 2026. The notes will be senior secured obligations of t…

Kept in their own lane. A press release is the company talking, not reporting.

Expected by Feb 24. Report dates come from the data provider's upcoming-earnings feed and are its estimate, not a date the company has set.

Article counts from the last market-wide feed page, across every symbol we track and not just IART · day move from the quote feed. Equal counts are listed alphabetically, not ranked. Coverage ≠ importance.

The feed is purely chronological. No materiality ranking, no hidden sentiment score. Timestamps are publisher-reported and arrive with no timezone, so they are read and shown on the US market clock (ET); thumbnails come from each article's image field; day moves from the quote feed. Copies of the same story are collapsed on link or normalized headline, and a company's press release is kept over any syndicated copy of it; "company's own words" means the release title leads with the company's name and the wire names no other organisation first as its issuer; "earnings-tied" is a keyword match while a report date is upcoming. Not investment advice.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.